Sirt1/Nrf2

Youping Zhang1, Hongkai Dai2, Man Lv3

  • 1Department of Emergency Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China; Department of Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.

概括

埃达拉治疗通过激活SIRT1/Nrf2通路,在小鼠中改善了败血症诱导的隔膜功能障碍 (SIDD). 这种干预减少了氧化应激和肌肉缩,为SIDD提供了潜在的治疗策略.